Michael E. Parsons

2.8k total citations
72 papers, 2.3k citations indexed

About

Michael E. Parsons is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael E. Parsons has authored 72 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 14 papers in Organic Chemistry and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael E. Parsons's work include Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (12 papers) and Ion Transport and Channel Regulation (10 papers). Michael E. Parsons is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (12 papers) and Ion Transport and Channel Regulation (10 papers). Michael E. Parsons collaborates with scholars based in United Kingdom, United States and Canada. Michael E. Parsons's co-authors include C. Robin Ganellin, G. J. DURANT, W. A. M. Duncan, Graham J. Durant, R.W. Brimblecombe, J. C. EMMETT, David J. Keeling, D. A. A. Owen, Robert J. Ife and Colin A. Leach and has published in prestigious journals such as Nature, The Journal of Immunology and Gastroenterology.

In The Last Decade

Michael E. Parsons

71 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Parsons United Kingdom 26 1.1k 664 423 390 361 72 2.3k
J. W. Black United Kingdom 13 1.1k 1.1× 887 1.3× 577 1.4× 233 0.6× 367 1.0× 36 2.6k
Gabriella Coruzzi Italy 26 811 0.8× 702 1.1× 478 1.1× 473 1.2× 262 0.7× 132 2.4k
W. A. M. Duncan United Kingdom 11 1.3k 1.2× 1.0k 1.5× 614 1.5× 291 0.7× 402 1.1× 23 3.0k
Nigel P. Shankley United States 26 1.6k 1.5× 767 1.2× 610 1.4× 184 0.5× 343 1.0× 84 2.9k
G. J. DURANT United Kingdom 16 804 0.7× 515 0.8× 272 0.6× 430 1.1× 96 0.3× 37 1.6k
R. Michael Snider United States 30 1.9k 1.8× 337 0.5× 667 1.6× 233 0.6× 247 0.7× 62 3.5k
Ann Barbier United States 29 1.4k 1.3× 756 1.1× 729 1.7× 184 0.5× 121 0.3× 66 2.8k
J. C. EMMETT United Kingdom 13 551 0.5× 290 0.4× 176 0.4× 397 1.0× 116 0.3× 22 1.4k
Günter Lambrecht Germany 30 1.3k 1.2× 116 0.2× 371 0.9× 292 0.7× 117 0.3× 84 2.7k
Jeanne‐Marie Lecomte France 21 1.2k 1.1× 834 1.3× 529 1.3× 82 0.2× 79 0.2× 44 2.7k

Countries citing papers authored by Michael E. Parsons

Since Specialization
Citations

This map shows the geographic impact of Michael E. Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Parsons more than expected).

Fields of papers citing papers by Michael E. Parsons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Parsons. The network helps show where Michael E. Parsons may publish in the future.

Co-authorship network of co-authors of Michael E. Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Parsons. A scholar is included among the top collaborators of Michael E. Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Parsons. Michael E. Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Charles W., Samuel D. Saibil, Thierry Le Bihan, et al.. (2017). Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation. The Journal of Immunology. 199(12). 4056–4065. 13 indexed citations
2.
Keir, Sandra, et al.. (2013). The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig. Pulmonary Pharmacology & Therapeutics. 26(3). 373–379. 18 indexed citations
3.
Parsons, Michael E., et al.. (2009). Characterisation of nicotine receptors on human peripheral blood mononuclear cells (PBMC). Inflammation Research. 58(1). 38–44. 13 indexed citations
4.
Begg, Malcolm, Nicholas Dale, Enrique Llaudet, Areles Molleman, & Michael E. Parsons. (2002). Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus‐longitudinal muscle preparation of the guinea‐pig ileum. British Journal of Pharmacology. 137(8). 1298–1304. 40 indexed citations
5.
Brampton, Christopher, et al.. (2000). An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflammation Research. 49(7). 311–319. 63 indexed citations
6.
Lee, John J. & Michael E. Parsons. (2000). Signaling Mechanisms Coupled to Presynaptic A1- and H3-Receptors in the Inhibition of Cholinergic Contractile Responses of the Guinea Pig Ileum. Journal of Pharmacology and Experimental Therapeutics. 295(2). 607–613. 2 indexed citations
7.
Williams, S. Janette & Michael E. Parsons. (1997). Evidence for a role for nitric oxide in relaxation of the frog oesophageal body to electrical field stimulation. British Journal of Pharmacology. 122(1). 179–185. 8 indexed citations
8.
Nalwalk, Julia W., et al.. (1996). Characterization of the antinociceptive properties of cimetidine and a structural analog.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 500–508. 44 indexed citations
9.
Garner, A., et al.. (1996). 1976 and all that!--20 years of antisecretory therapy.. Gut. 39(6). 784–786. 13 indexed citations
10.
Pope, Andrew J., Mark K. Boehm, Colin A. Leach, et al.. (1995). Properties of the reversible, K+-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity. Biochemical Pharmacology. 50(10). 1543–1549. 15 indexed citations
11.
Parsons, Michael E., et al.. (1995). properties of the reversible, K+-competitive inhibitor of the gastric H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties. Biochemical Pharmacology. 50(10). 1551–1556. 7 indexed citations
12.
Parsons, Michael E. & A. Garner. (1995). drug development in gastroenterology—the changing view of industry. Alimentary Pharmacology & Therapeutics. 9(5). 457–463. 11 indexed citations
13.
Williams, S. Janette & Michael E. Parsons. (1995). Nitric oxide, an enteric nonadrenergic‐noncholinergic relaxant transmitter: evidence using phosphodiesterase V and nitric oxide synthase inhibition. British Journal of Pharmacology. 116(2). 1789–1796. 25 indexed citations
14.
Leach, Colin A., Thomas H. Brown, Robert J. Ife, et al.. (1995). Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 4. Identification of an Inhibitor with an Intermediate Duration of Action. Journal of Medicinal Chemistry. 38(14). 2748–2762. 22 indexed citations
15.
Ife, Robert J., Thomas H. Brown, Peter Blurton, et al.. (1995). Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 5. Substituted 2,4-Diaminoquinazolines and Thienopyrimidines. Journal of Medicinal Chemistry. 38(14). 2763–2773. 38 indexed citations
16.
17.
Parsons, Michael E., et al.. (1989). Adrenergic and purinergic neurotransmission in arterial resistance vessels of the cat intestinal circulation. European Journal of Pharmacology. 164(1). 23–33. 18 indexed citations
18.
Hills, Judith M., et al.. (1989). 3‐Aminopropylphosphinic acid—a potent, selective GABAB receptor agonist in the guinea‐pig ileum and rat anococcygeus muscle. British Journal of Pharmacology. 97(4). 1292–1296. 25 indexed citations
19.
Ganellin, C. Robin, R R Griffiths, B. K. Leigh, et al.. (1988). Zolantidine (SK&F 95282) is a potent selective brain‐penetrating histamine H2‐receptor antagonist. British Journal of Pharmacology. 93(1). 69–78. 57 indexed citations
20.
Brimblecombe, R.W., W. A. M. Duncan, G. J. DURANT, et al.. (1975). Proceedings: The pharmacology of cimetidine, a new histamine H2-receptor antagonist.. British Journal of Pharmacology. 53(3). 435. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. W. Black Breakdown of academic impact, for papers by Gabriella Coruzzi Breakdown of academic impact, for papers by W. A. M. Duncan Breakdown of academic impact, for papers by Nigel P. Shankley Breakdown of academic impact, for papers by G. J. DURANT Breakdown of academic impact, for papers by R. Michael Snider Breakdown of academic impact, for papers by Ann Barbier Breakdown of academic impact, for papers by J. C. EMMETT Breakdown of academic impact, for papers by Günter Lambrecht Breakdown of academic impact, for papers by Jeanne‐Marie Lecomte
Rankless by CCL
2026